EUVIMEDEUVIMED entdecken
Crossref

Real world data are needed to establish safety of adjuvant immune checkpoint inhibitors after pneumonectomy

Ikuo Sekine

AME Clinical Trials Review · 2023

DOI: 10.21037/actr-23-16 ↗

Kurz gefasst

Fachartikel in der Zeitschrift AME Clinical Trials Review, 2023. Verfasst von Ikuo Sekine.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Sekine, I. (2023). Real world data are needed to establish safety of adjuvant immune checkpoint inhibitors after pneumonectomy. AME Clinical Trials Review. https://doi.org/10.21037/actr-23-16

Vancouver

Sekine I. Real world data are needed to establish safety of adjuvant immune checkpoint inhibitors after pneumonectomy. AME Clinical Trials Review. 2023. doi:10.21037/actr-23-16

BibTeX
@article{Sekine2023,
  author = {Sekine, Ikuo},
  title = {Real world data are needed to establish safety of adjuvant immune checkpoint inhibitors after pneumonectomy},
  journal = {AME Clinical Trials Review},
  year = {2023},
  doi = {10.21037/actr-23-16}
}
Kostenlos starten →